NPS Pharma to Present at Oppenheimer Healthcare Conference
December 04 2014 - 8:10AM
Business Wire
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present
at the Oppenheimer 25th Annual Healthcare Conference in New York on
Thursday, December 11, 2014 at 9:45 a.m. ET. The presentation will
be available as a live webcast with a replay available
approximately three hours after the presentation has concluded.
Interested parties may access the webcast from the investors’
calendar of events page on the NPS Pharma website at
http://ir.npsp.com/events.cfm.
About NPS Pharma
NPS Pharma is a global biopharmaceutical company pioneering and
delivering therapies that transform the lives of patients with rare
diseases. The company’s current therapeutic areas of focus are
gastrointestinal disease and endocrine disorders. These include
Short Bowel Syndrome, a potentially fatal gastrointestinal disorder
in which patients may have to rely on parenteral nutrition for
their survival; Hypoparathyroidism, a complex endocrine disorder in
which the parathyroid glands are either absent or damaged, and the
body produces insufficient or no parathyroid hormone; and Autosomal
Dominant Hypocalcemia, an ultra-rare, genetic disorder of calcium
homeostasis caused by mutations of the calcium-sensing receptor
gene. NPS Pharma continues to seek in-licensing opportunities to
develop new therapies for a broad range of rare diseases, and
complements its proprietary programs with a royalty-based portfolio
of products and product candidates that includes agreements with
Amgen, GlaxoSmithKline, Janssen Pharmaceuticals, and Kyowa Hakko
Kirin. NPS Pharma has operations in the U.S., Canada, Europe, Latin
America and Japan. Learn more at: www.npsp.com.
“NPS Pharma” and “NPS Pharmaceuticals” are the company's
trademarks.
NPS Pharmaceuticals, Inc.Gail Brophy, + 1
908-450-5335gbrophy@npsp.com
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Jul 2023 to Jul 2024